Clinical Trials in Chicago

Showing 6441-6460 of 15,574 trials

A Dose Finding Study to Treat Bone Tumor(s)

NCT06008483

To determine the Maximum Tolerated Dose (MTD) of CycloSam®, Samarium-153-DOTMP (Sm-153-DOTMP), a radiopharmaceutical that delivers radiation to the bone when injected, given as a tandemly administered pair of doses to subjects with one or more solid tumor(s) in the bone or metastatic solid tumors to the bone that are visible on bone scan.

Bone CancerBone TumorSolid Tumor+2 more

QSAM Therapeutics, Inc.17 participantsStarted Apr 2022

Chicago, Illinois, United States • Columbia, Missouri, United States • New Brunswick, New Jersey, United States +1 more locations

COMPLETED2.2 miles

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT01770951

The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.

Atypical Hemolytic Uremic Syndrome (aHUS)

Alexion Pharmaceuticals, Inc.30 participantsStarted Aug 2009

Dunwoody, Georgia, United States • Chicago, Illinois, United States • Portland, Maine, United States +20 more locations

A Dose Finding Study to Treat Bone Tumor(s)

A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Find Trials by Condition in Chicago

Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma

Real World Perspectives on Advancements in Hearing Aid Technology

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM)

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

BioVentrix Revivent TC™ System Clinical Study

Study of Sargramostim in Patients With COVID-19

TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence

M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)

A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer

Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study

Pilot Clinical Performance of a Silicone Hydrogel Lens for Up to Six Nights of Extended Wear

A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome